Unlock FDA Funding for Advanced Drug Development
Posted: February 13, 2019
This grant closed on Apr 22, 2019. We have found similar active grants for you below.
Summary
This FDA grant is for researchers and businesses developing innovative methods for assessing the quality of complex new and generic drugs, including biological products. Funding supports advancements in formulation, analysis, and manufacturing to improve drug safety and effectiveness.
Eligibility
Full Description
The purpose of this program is to support research activities that expand the knowledge base related to complex products and formulation development, analysis, and manufacturing control to advance risk-based quality assessment of new and generic drug products. We will also consider biological products relevant to CDER (e.g., monoclonal antibodies and therapeutic proteins) for this announcement.